Top News

Dr. Reddy's stock dipped slightly after the news, but the bigger story is how this shakes up the global market.
Novo Nordisk (the original Ozempic maker) might have a tough time keeping its lead as generics get popular, especially since Health Canada says costs could drop by up to 90%.
For anyone affected by diabetes or obesity, this could mean easier access to important medications at a much lower price.